GC
GILD icon

Gould Capital’s Gilead Sciences GILD Stock Holding History

Gould Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69M Sell
12,160
-1,226
-9% -$172K 1.03% 33
2025
Q4 		$1.64M Sell
13,386
-72
-0.5% -$8.75K 1.01% 33
2025
Q3 		$1.49M Buy
13,458
+131
+1% +$14.9K 0.92% 36
2025
Q2 		$1.48M Sell
13,327
-244
-2% -$26K 0.99% 32
2025
Q1 		$1.52M Sell
13,571
-2,126
-14% -$219K 1.06% 29
2024
Q4 		$1.45M Sell
15,697
-431
-3% -$38.8K 1.01% 32
2024
Q3 		$1.35M Buy
16,128
+2,927
+22% +$223K 0.89% 33
2024
Q2 		$906K Buy
13,201
+756
+6% +$50.5K 0.64% 42
2024
Q1 		$912K Buy
12,445
+1,802
+17% +$139K 0.64% 43
2023
Q4 		$862K Sell
10,643
-1,035
-9% -$80.5K 0.63% 41
2023
Q3 		$865K Buy
11,678
+817
+8% +$62.8K 0.7% 40
2023
Q2 		$837K Buy
10,861
+10,710
+7,093% +$854K 0.64% 41
2023
Q1 		$12.6K Buy
151
+51
+51% +$4.22K 0.01% 140
2022
Q4 		$8.59K Sell
100
-25
-20% -$1.98K 0.01% 152
2022
Q3 		$8K Buy
+125
New +$7.88K 0.01% 148

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Gould Capital's GILD Position: Q1 2026 in Review

Gould Capital reduced its Gilead Sciences (GILD) stake by 9.2% in Q1 2026, selling an estimated $172K and leaving 12,160 shares worth $1.69M. The position accounts for 1.03% of the portfolio, ranked #33.

Gould Capital first reported a position in GILD in Q3 2022 and has held it in 15 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Gould Capital held 12,160 shares of Gilead Sciences worth $1.69M as of Q1 2026.
  • Gould Capital sold 1,226 Gilead Sciences shares in Q1 2026, an estimated $172K.
  • Gilead Sciences made up 1.03% of Gould Capital's portfolio in Q1 2026, its #33 holding.
  • Gould Capital first reported a position in Gilead Sciences in Q3 2022 and has held it in 15 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Gould Capital's 13F filing for Q1 2026, filed 18 May 2026.